Vitamin Retailer is recognized as the dietary supplement industry’s leading business magazine. VR was the first trade magazine to specifically cover the category of dietary supplements. This trail-blazing editorial focus has firmly established VR as one of the most credible and reliable sources of information pertaining to dietary supplements and related products which is why Provinal chose to work together with them. Read more…
Tersus Life Sciences returns from another successful Supply Side West!
Thanks for a great show this year – We got to meet with and form relationships with new and old friends.
If you didn’t get a chance to set up a meeting with us this year, you can always reach us at tersus@tersuslifesciences.com or 239-390-1226 and we’ll immediately get back with you. We hope to see you next year October 23-27, 2023!
Palmitoleic acid: An omega-7 fatty acid for inflammation & metabolic wellness
Although the omega-3, -6, -7 and -9 category of fatty acids has grown consistently over the past few decades—and the worldwide market for fatty acids will grow from nearly $13.5 billion in 2018 to $17.5 billion by 20231—the public and the dietary supplement industry know the least about the value of the omega-7 fatty acids. This article will explain the value of an extremely well-researched omega-7 fatty acid, palmitoleic acid. https://tersuslifesciences.com/wp-content/uploads/2022/10/2.-Palmitoleic-acid-An-omega-7-fatty-acid-for-inflammation-metabolic-wellness-2.pdf
Provinal® Ethyl Ester NDI Notification Accepted by U.S. FDA
Tersus Life Sciences LLC (“Tersus” – Bonita Springs, Florida) announces that its submission demonstrating the safety of its patented and proprietary ingredient, Provinal®, has been accepted by the U.S. Food and Drug Administration under the FDA’s New Dietary Ingredient Notification process.
After rigorous evaluation of significant preclinical and clinical data, the FDA decided that the evidence presented substantiated the safety of Provinal® and accepted the NDI with no objection.
Tersus’ NDI submission process was led and coordinated by Dr. Tina Sampalis, M.D., PhD, Tersus’ Chief Scientific Officer along with the assistance of Clemson University and Harvard School of Medicine, Harvard Public Health. Dr. Sampalis states “We are extremely pleased to achieve such important milestones for Provinal® and Tersus. On one hand, the safety of Provinal is acknowledged by the US-FDA. Furthermore, we are proud that Tersus is the first ever company to prove that ethyl esters comply with the requirements to be classified as a dietary supplement. An achievement that has been considered unattainable in the Industry for many years. The acceptance of both the safety and supplement classification of Provinal® are landmark milestones which, along with the significant international intellectual property protection secured, place Tersus and Provinal® in a high league of their own.”
Unique advantages of Tersus Provinal® to date:
1. First ethyl ester form of fish oil to meet the rigorous NDI notification requirements of the FDA.
2. Novel patented fish oil composition consisting of no less than 50% palmitoleic acid and no more than 1% palmitic acid.
3. Currently supported by 10 issued and enforceable international patents of which seven are in the USA and multiple pending patents worldwide
4. Provinal safety and efficacy are proven by clinical and preclinical studies conducted with the same ingredient as in the commercialized product
Timothy Gooding, CEO and Chairman of Tersus Life Sciences commented, “Receiving NDI status further validates the rigorous path Tersus has always endorsed by reinforcing the importance of evidence-based claims substantiated by preclinical and clinical research. This has been our path over the last five years and continues rigorously today for Provinal®. Achieving NDI status represents another very significant milestone in the development and commercialization of Provinal® and further validates the safety and quality of the product and our regulatory progress being made in multiple jurisdictions.”
Tersus remains committed to substantiating Provinal’s® health benefits with in vitro, in-vivo and human clinical focusing on improvements in blood lipid markers, improved vascular function, eye health and improved glucose metabolism.
Tersus Life Sciences joins the Global Organization of EPA & DHA (GOED)
BONITA SPRINGS, FL October 13, 2021 | Tersus Life Sciences is now the proud member of GOED – the Global Organization of EPA & DHA.
GOED represents the worldwide EPA and DHA omega-3 industry, and its membership is built on a quality standard unparalleled in the market. Their mission is to increase consumption of EPA and DHA omega-3s, regardless of the source, and ensure that their members produce quality products that consumers can trust.
With this partnership, Tersus Life Sciences is supporting global education efforts — for consumers, media, and healthcare professionals — about the importance of EPA and DHA omega-3s and omega-7s. In collaboration with GOED, it also allows the furthering of science around EPA and DHA omega-3s and omega-7s and advocation with governments and NGOs around the world.
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »